$ONEI
OneMeta Inc Stock $onei

$onei Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000149315224012247 Filed on April 01, 2024

Income Statement

Concept	2023 Q4	2023	2022
Revenue	$13.78K	$70.90K	$1.295K
YoY Change		5375.14%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$151.6K	$4.732M
YoY Change
% of Gross Profit
Research & Development	$217.2K	$757.3K	$157.7K
YoY Change		380.35%
% of Gross Profit
Depreciation & Amortization	$97.95K	$391.8K
YoY Change
% of Gross Profit
Operating Expenses	$368.7K	$6.175M	$1.311M
YoY Change		370.82%
Operating Profit		-$6.104M	-$1.310M
YoY Change		365.87%
Interest Expense	-$11.71K	$43.17K	$33.37K
YoY Change		29.37%
% of Operating Profit
Other Income/Expense, Net		-$43.17K	-$33.37K
YoY Change		29.37%
Pretax Income	-$1.052M	-$6.147M
YoY Change
Income Tax
% Of Pretax Income
Net Earnings	-$1.052M	-$6.147M	-$1.344M
YoY Change		357.52%
Net Earnings / Revenue	-7636.65%	-8669.68%	-103750.73%
Basic Earnings Per Share		-$0.22	-$0.06
Diluted Earnings Per Share	-$0.03	-$0.22	-$0.06
COMMON SHARES
Basic Shares Outstanding	33.00M shares	28.55M shares	22.25M shares
Diluted Shares Outstanding		28.55M shares	22.25M shares

Balance Sheet

Concept	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.130M	$1.130M
YoY Change
Cash & Equivalents	$1.130M
Short-Term Investments
Other Short-Term Assets	$6.820K	$6.820K
YoY Change
Inventory
Prepaid Expenses
Receivables	$6.935K	$6.940K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.144M	$1.144M
YoY Change	185.42%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets		$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$1.144M	$1.144M
Total Long-Term Assets		$0.00
Total Assets	$1.144M	$1.144M
YoY Change	-22.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$522.9K	$522.9K
YoY Change	38.38%
Accrued Expenses	$281.0K	$281.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$222.0K	$222.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.026M	$1.026M
YoY Change	-1.57%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.026M	$1.026M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$1.026M	$1.026M
YoY Change	-1.57%
SHAREHOLDERS EQUITY
Retained Earnings	-$33.91M
YoY Change	22.14%
Common Stock	$33.00K
YoY Change	32.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$117.8K	$117.8K
YoY Change
Total Liabilities & Shareholders Equity	$1.144M	$1.144M
YoY Change	-22.63%

Cashflow Statement

Concept	2023 Q4	2023	2022
OPERATING ACTIVITIES
Net Income	-$1.052M	-$6.147M	-$1.344M
YoY Change		357.52%
Depreciation, Depletion And Amortization	$97.95K	$391.8K
YoY Change
Cash From Operating Activities	-$832.4K	-$2.378M	-$722.1K
YoY Change		229.28%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00		-$210.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$3.107M	$1.326M
YoY Change		134.41%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.749M	$3.107M	$1.326M
YoY Change		134.41%
NET CHANGE
Cash From Operating Activities	-832.4K	-$2.378M	-$722.1K
Cash From Investing Activities	0.000		-$210.0K
Cash From Financing Activities	1.749M	$3.107M	$1.326M
Net Change In Cash	916.7K	$729.2K	$393.4K
YoY Change		85.39%
FREE CASH FLOW
Cash From Operating Activities	-$832.4K	-$2.378M	-$722.1K
Capital Expenditures	$0.00	$0.00
Free Cash Flow	-$832.4K	-$2.378M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001388295
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent		usd
CY2023Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet		usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions		usd
CY2022	ONEI	Additional Shares Issued For Prior Year Software Acquisition AdditionalSharesIssuedForPriorYearSoftwareAcquisition		usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2022	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther		usd
CY2023	us-gaap	Payments For Software PaymentsForSoftware		usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	ONEI	Reclassification Of Temporary Equity ReclassificationOfTemporaryEquity		usd
CY2023	us-gaap	Stock Issued1 StockIssued1		usd
CY2022	ONEI	Contributed Capital ContributedCapital		usd
CY2023Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	9300000	usd
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	32995460	shares
CY2023	dei	Auditor Name AuditorName	M&K CPAS, PLLC
CY2023	dei	Auditor Firm AuditorFirmId	2738
CY2023	dei	Auditor Location AuditorLocation	The Woodlands, TX
CY2023Q4	us-gaap	Cash Cash	1129935	usd
CY2022Q4	us-gaap	Cash Cash	400703	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6935	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6820	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1143690	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	400703	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	1077475	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1077475	usd
CY2023Q4	us-gaap	Assets Assets	1143690	usd
CY2022Q4	us-gaap	Assets Assets	1478178	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	522917	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	377883	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1025919	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1042308	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1025919	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1042308	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32995460	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32995460	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24983593	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24983593	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	32996	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	24984	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33992707	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24156001	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33908796	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27761733	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	117771	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3580746	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1143690	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1478178	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	70903	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1295	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	70903	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1295	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	757267	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	157650	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4074187	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	669550	usd
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	192747	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	49800	usd
CY2023	ONEI	Legal And Professional Fees LegalAndProfessionalFees	464930	usd
CY2022	ONEI	Legal And Professional Fees LegalAndProfessionalFees	434499	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	685666	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	6174797	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1311499	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-6103894	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1310204	usd
CY2023	us-gaap	Interest Expense InterestExpense	43169	usd
CY2022	us-gaap	Interest Expense InterestExpense	33368	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-43169	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-33368	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6147063	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1343572	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28546287	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3783458	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1325501	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	214123	usd
CY2022	ONEI	Imputed Interest ImputedInterest	6660	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1343572	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3580746	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3580746	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3107120	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	145003	usd
CY2023	ONEI	Adjustments To Additional Paid In Capital Contributed Capital AdjustmentsToAdditionalPaidInCapitalContributedCapital	351459	usd
CY2023	ONEI	Imputed Interest ImputedInterest	6660	usd
CY2023	ONEI	Stock Issued During Period Value Additional Shares Issued For Prior Year Software Acquisition StockIssuedDuringPeriodValueAdditionalSharesIssuedForPriorYearSoftwareAcquisition	132960	usd
CY2023	ONEI	Stock Issued During Period Value Reclassification Of Equity StockIssuedDuringPeriodValueReclassificationOfEquity	6102378	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6147063	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	117771	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	117771	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6147063	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1343572	usd
CY2023	ONEI	Imputed Interests ImputedInterests	6660	usd
CY2022	ONEI	Imputed Interests ImputedInterests	6660	usd
CY2023	ONEI	Additional Shares Issued For Prior Year Software Acquisition AdditionalSharesIssuedForPriorYearSoftwareAcquisition	2218722	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	145003	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	214123	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	391809	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	97952	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	685666	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6935	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	6820	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	614986	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-54863	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-279916	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	357555	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2377888	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-722145	usd
CY2022	us-gaap	Payments For Software PaymentsForSoftware	210000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-210000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3107120	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1325501	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3107120	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1325501	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	729232	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	393356	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	400703	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7347	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1129935	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	400703	usd
CY2023	ONEI	Expenses Paid ExpensesPaid	469952	usd
CY2022	ONEI	Expenses Paid ExpensesPaid	113439	usd
CY2023	ONEI	Reclassification Of Temporary Equity ReclassificationOfTemporaryEquity	6102378	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	965427	usd
CY2023	ONEI	Contributed Capital ContributedCapital	351459	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_846_eus-gaap--UseOfEstimates_zulVWm5QwKBd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zjim2QX7yb0l">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates in the accompanying financial statements involving the valuation of common stock and stock based compensation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	685666	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	70903	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1295	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	0	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	0	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1650000	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	100000	shares
CY2023	ONEI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Issuance SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsIssuance	1550000	shares
CY2023	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	611764	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	391809	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	97952	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	685666	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	1077475	usd
CY2023	ONEI	Imputed Interests ImputedInterests	6660	usd
CY2022	ONEI	Imputed Interests ImputedInterests	6660	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	33299	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	22198	usd
CY2023	ONEI	Contributed Capital ContributedCapital	351459	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6023067	shares
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3107120	usd
CY2023	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	216000	shares
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	83434	usd
CY2023Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	1772800	shares
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.075
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	3563753	shares
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1325501	usd
CY2008Q2	us-gaap	Convertible Preferred Stock Terms Of Conversion ConvertiblePreferredStockTermsOfConversion	1 to 1.25
CY2015Q4	us-gaap	Convertible Preferred Stock Terms Of Conversion ConvertiblePreferredStockTermsOfConversion	1 to 11
CY2015Q4	ONEI	Percentage Of Outstanding Votes PercentageOfOutstandingVotes	0.51	pure
CY2023	ONEI	Warrant Issued WarrantIssued	350000	shares
CY2023Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	72785	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	9500	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1291000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	282000	usd
CY2023	ONEI	Income Tax Reconciliation Trueup And Nondeductible Expenses IncomeTaxReconciliationTrueupAndNondeductibleExpenses	1952000	usd
CY2022	ONEI	Income Tax Reconciliation Trueup And Nondeductible Expenses IncomeTaxReconciliationTrueupAndNondeductibleExpenses	-45000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-3243000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-237000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3525000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	282000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3525000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	282000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	16789000	usd
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001493152-24-012247-index-headers.html	Edgar Link	pending
0001493152-24-012247-index.html	Edgar Link	pending
0001493152-24-012247.txt	Edgar Link	pending
0001493152-24-012247-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
onei-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
onei-20231231_cal.xml	Edgar Link	unprocessable
onei-20231231_lab.xml	Edgar Link	unprocessable
onei-20231231_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
onei-20231231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ONEI
OneMeta Inc Stock $onei

2023 Q4 Form 10-K Financial Statement

#000149315224012247 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONEI OneMeta Inc Stock $onei

2023 Q4 Form 10-K Financial Statement

#000149315224012247 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONEI
OneMeta Inc Stock $onei